drugset / Trial / NCT03489304
Zaleplon in HIV Patients With Depression
NaSingle-groupOpen-labelTreatment
Summary
In HIV positive patients with sleep onset insomnia and receiving pharmacologic treatment for comorbid depression, the proposed study aims to evaluate the impact of zaleplon on sleep measures determined by insomnia severity index (ISI) and Epworth sleepiness scale (ESS).
Timeline
- Start
- 2014-04-03
- Primary completion
- 2015-02-04
- Completion
- 2015-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zaleplon | Small molecule | 5 mg | — |
| Subject | Zaleplon | Small molecule | 10 mg | — |